Coronary atherosclerotic heart disease
Conditions
Interventions
H2-O2 gas inhalation group:H2-O2 gas inhalation
Control group:N2-O2 gas inhalation
Sponsors
The Affiliated Taian Central Hospital of Qingdao University
Eligibility
Sex/Gender
All
Age
25 Years to 75 Years
Inclusion criteria
Inclusion criteria: ?patients with chest pain, such as patients with metabolic cardiomyopathy or coronary artery disease (angina), who are awaiting investigation after the disease's initial manifestation; ?The patient sought a diagnosis of coronary heart disease from the physician; ?Patients who have taken statins; ?Age range of 25 to 75; ?The patient gave informed consent and freely took part in the study.
Exclusion criteria
Exclusion criteria: ? Patients with severe chronic disease history, such as diabetes, malignant tumor, liver and kidney dysfunction, rheumatic immune disease, Hyperuricemia, thyroid dysfunction, asthma, depression, etc; ? Pregnant or lactating women; ? Patients with AIDS and syphilis; ? Clinical researchers are impacted by poor compliance or an unwillingness to comply with the examination.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Electrocardiogram; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pittsburgh sleep quality index,PSQI;Blood lipid detection: total cholesterol, triglyceride, High-density lipoprotein cholesterol, low-density lipoprotein cholesterol;Inflammatory factor: c-reactive protein;Liver function;Renal function;Seattle angina quantification table; | — |
Countries
China
Contacts
Public ContactQingbin Ni,Guohua Song
The Affiliated Taian Central Hospital of Qingdao University,Shandong First Medical University (Shandong Academy of Medical Sciences)
Outcome results
None listed